ARMC1-PEX19 Fusion FISH Probe
The ARMC1-PEX19 Fusion FISH Probe is used to confirm a fusion of the ARMC1 and PEX19 genes. The fusion of the ARMC1 and PEX19 genes has been associated with Breast Invasive Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
SKU | Test Kits | Buffer | Dye Color | Order Now |
---|---|---|---|---|
ARMC1-PEX19-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL | ||
ARMC1-PEX19-20-RERE | 20 (40 μL) | 200 μL | ||
ARMC1-PEX19-20-REOR | 20 (40 μL) | 200 μL | ||
ARMC1-PEX19-20-REGO | 20 (40 μL) | 200 μL | ||
ARMC1-PEX19-20-REGR | 20 (40 μL) | 200 μL | ||
ARMC1-PEX19-20-REAQ | 20 (40 μL) | 200 μL | ||
ARMC1-PEX19-20-ORRE | 20 (40 μL) | 200 μL | ||
ARMC1-PEX19-20-OROR | 20 (40 μL) | 200 μL | ||
ARMC1-PEX19-20-ORGO | 20 (40 μL) | 200 μL | ||
ARMC1-PEX19-20-ORAQ | 20 (40 μL) | 200 μL | ||
ARMC1-PEX19-20-GORE | 20 (40 μL) | 200 μL | ||
ARMC1-PEX19-20-GOOR | 20 (40 μL) | 200 μL | ||
ARMC1-PEX19-20-GOGO | 20 (40 μL) | 200 μL | ||
ARMC1-PEX19-20-GOGR | 20 (40 μL) | 200 μL | ||
ARMC1-PEX19-20-GOAQ | 20 (40 μL) | 200 μL | ||
ARMC1-PEX19-20-GRRE | 20 (40 μL) | 200 μL | ||
ARMC1-PEX19-20-GROR | 20 (40 μL) | 200 μL | ||
ARMC1-PEX19-20-GRGO | 20 (40 μL) | 200 μL | ||
ARMC1-PEX19-20-GRGR | 20 (40 μL) | 200 μL | ||
ARMC1-PEX19-20-GRAQ | 20 (40 μL) | 200 μL | ||
ARMC1-PEX19-20-AQRE | 20 (40 μL) | 200 μL | ||
ARMC1-PEX19-20-AQOR | 20 (40 μL) | 200 μL | ||
ARMC1-PEX19-20-AQGO | 20 (40 μL) | 200 μL | ||
ARMC1-PEX19-20-AQGR | 20 (40 μL) | 200 μL | ||
ARMC1-PEX19-20-AQAQ | 20 (40 μL) | 200 μL |
PEX19 Gene Summary
This gene is necessary for early peroxisomal biogenesis. It acts both as a cytosolic chaperone and as an import receptor for peroxisomal membrane proteins (PMPs). Peroxins (PEXs) are proteins that are essential for the assembly of functional peroxisomes. The peroxisome biogenesis disorders (PBDs) are a group of genetically heterogeneous autosomal recessive, lethal diseases characterized by multiple defects in peroxisome function. These disorders have at least 14 complementation groups, with more than one phenotype being observed for some complementation groups. Although the clinical features of PBD patients vary, cells from all PBD patients exhibit a defect in the import of one or more classes of peroxisomal matrix proteins into the organelle. Defects in this gene are a cause of Zellweger syndrome (ZWS), as well as peroxisome biogenesis disorder complementation group 14 (PBD-CG14), which is also known as PBD-CGJ. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2010]
Gene Name: Peroxisomal Biogenesis Factor 19
Chromosome: CHR1: 160246598 -160254941
Locus: 1q23.2
ARMC1 Gene Summary
The Armadillo Repeat Containing 1 (ARMC1) gene is located on chr8 :66514690-66546452 at 8q13.1.
Gene Name: Armadillo Repeat Containing 1
Chromosome: CHR8: 66514690 -66546452
Locus: 8q13.1
Gene Diseases
The ARMC1 PEX19 Fusion has been associated with the following diseases:
Disease Name |
---|
Breast Invasive Carcinoma |
FISH Probe Protocols
Protocol, Procedure, or Form Name | Last Modified | Download |
---|